|
Vaccine Detail
rMVTT- HPV16-E6/E7 |
Vaccine Information |
- Vaccine Name: rMVTT- HPV16-E6/E7
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0004761
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- E6
gene engineering:
- Type: Recombinant protein preparation
- Description: (Zhi et al., 2002)
- Detailed Gene Information: Click Here.
- E7
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: (Zhi et al., 2002) In this vaccine, the HPV16 early E6 and E7 genes were expressing by a vaccinia virus TianTan vector.
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Host Strain: C57 BL/6
- Vaccination Protocol: Mice were vaccinated with VmE6E7 (Zhi et al., 2002).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: Mice were challenged by syngeneic HPV16E6 and E7 transformed tumor cells (Zhi et al., 2002).
- Efficacy: The mice vaccinated expressed retarded or prevented tumor development (Zhi et al., 2002).
|
References |
Zhi et al., 2002: Zhi H, Han L, Ren J, Tian H, Luo W, Liang Y, Ruan L. [Construction of recombinant vaccinia virus co-expressing mutant E6 plus E7 proteins and detection of its immunogenicity and antitumor response]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology. 2002; 16(4); 341-344. [PubMed: 12665900].
|
|